Concurrent chemoradiotherapy (cCRT) followed by one year of consolidation durvalumab is
the current standard-of-care for patients with unresectable stage III non-small cell lung …

Immunotherapy, particularly with immune checkpoint inhibitors, has significantly transformed
cancer treatment. Despite its success, many patients struggle to respond adequately or …

The concepts of personalized medicine and personalized oncology are steadily gaining
steam in recent years. Yet, at times it may seem that personalized radiotherapy (RT) …

Stereotactic ablative radiotherapy (SABR) is increasingly used for the treatment of early-
stage non-small cell lung cancer (ES-NSCLC) and for pulmonary metastases. In patients …

Purpose Only a subset of patients with severe emphysema qualify for lung volume reduction
surgery or endobronchial valves. We previously demonstrated that stereotactic ablative …

Simple Summary Surface tracking based on optical cameras is often used to reduce the
imaging dose while maintaining precision during stereotactic ablative body radiotherapy. A …

Background Currently, main treatment strategies for early-stage non-small cell lung cancer
(ES-NSCLC) disease are surgery or stereotactic body radiation therapy (SBRT), with …

Abstract Background and Purpose Histology was found to be an important prognostic factor
for local tumor control probability (TCP) after stereotactic body radiotherapy (SBRT) of early …

This prospective feasibility trial investigated pulmonary interstitial lymphography to identify
thoracic primary nodal drainage (PND). A post-hoc analysis of nodal recurrences was …

Abstract Background and Purpose Concerns over chest wall toxicity has led to debates on
treating tumors adjacent to the chest wall with single-fraction stereotactic ablative …